Elevated FTO alleviates sepsisinduced acute kidney injury by regulating macrophage inflammatory phenotypes

Xiaona Chen1, Ziqi Sun2, Jiabo Chen2

  • 1School of Medicine, Southern University of Science and Technology, Shenzhen, Guangdong 518055, P.R. China.

Insights

Fat mass and obesity-associated protein (FTO) is downregulated in sepsis-induced acute kidney injury (SAKI). Restoring FTO levels reduces inflammation and kidney damage by targeting matrix metalloproteinase 9 (MMP-9).

Area of Science:

  • Molecular Biology
  • Immunology
  • Nephrology

Background:

  • Sepsis-induced acute kidney injury (SAKI) involves dysregulated N6-methyladenosine (m6A) modification, leading to excessive inflammation and organ damage.
  • Fat mass and obesity-associated protein (FTO) is an m6A demethylase implicated in various biological processes.
  • Identifying key molecular regulators in SAKI is crucial for developing effective therapeutic strategies.

Purpose of the Study:

  • To investigate the role of FTO and its associated m6A pathway in SAKI.
  • To elucidate the molecular mechanism by which FTO influences inflammation and kidney injury during sepsis.
  • To explore the therapeutic potential of targeting the FTO/m6A axis in SAKI.

Main Methods:

  • Bioinformatic analysis of transcriptomic datasets (GSE32707, GSE69063) from sepsis patients.
  • In vivo studies using a cecal ligation and puncture (CLP) model in mice to assess FTO expression and m6A modification in renal tissues and peritoneal macrophages.
  • In vitro experiments involving lipopolysaccharide (LPS)-stimulated macrophages to evaluate the impact of FTO on cytokine production and MMP-9 translation.
  • Multiomic analysis to identify direct targets of FTO.

Main Results:

  • FTO was significantly downregulated in the peripheral blood of sepsis patients and in the kidneys and macrophages of septic mice.
  • Increased FTO levels correlated with reduced mortality and kidney damage in septic mice.
  • Upregulation of FTO in macrophages decreased proinflammatory cytokine production.
  • Matrix metalloproteinase 9 (MMP-9) was identified as a direct translational target of FTO.
  • Reduced MMP-9 levels exacerbated inflammatory responses and renal injury in both in vivo and in vitro models.

Conclusions:

  • The FTO/m6A/MMP-9 axis plays a critical role in regulating proinflammatory cytokine secretion during SAKI.
  • FTO downregulation contributes to renal injury in sepsis through increased MMP-9 translation.
  • Targeting the FTO/m6A/MMP-9 pathway presents a promising therapeutic strategy for mitigating kidney damage in sepsis.

Related Concept Videos

Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
865
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
549
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
254
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
791
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
287